Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)

NCT03083951 is registered in ClinicalTrials.gov with Pere Planellas Giné as lead sponsor.

NCT NCT03083951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03083951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)
Lead sponsor
Pere Planellas Giné
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2017
Completion date
January 1, 2023
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, sigmoid cancer